Read + Share
Amedeo Smart
Independent Medical Education
Xu P, Zhu Y, Shi ZY, Wang L, et al. A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma. Blood 2025 Aug 19:blood.2025028649. doi: 10.1182/blood.2025028649.PMID: 40829156
Email
LinkedIn
Privacy Policy